Seth A. Wander
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Advanced Breast Cancer Therapies 74
- Oncology 57
- Cancer Treatment and Pharmacology 24
- HER2/EGFR in Cancer Research 23
- Cancer-related Molecular Pathways 16
- Co-authors
- Joyce M. Slingerland (11 shared papers)Aditya Bardia (43 shared papers)Laura M. Spring (25 shared papers)Bryan T. Hennessy (2 shared papers)Dekuang Zhao (7 shared papers)Beverly Moy (21 shared papers)Amir Fathi (4 shared papers)Fabrice André (1 shared paper)
- Journals
- Cancer Research (26 papers)Journal of Clinical Oncology (24 papers)Clinical Cancer Research (9 papers)Blood (4 papers)JCO Precision Oncology (4 papers)
- Partner nations
- United StatesItalyIsrael
In The Last Decade
Seth A. Wander
102 papers receiving 3.0k citations
Seth A. Wander's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.3k
- Cancer Research 689
- Pulmonary and Respiratory Medicine 1.1k
- Genetics 304
- Molecular Biology 1.3k
Countries citing papers authored by Seth A. Wander
This map shows the geographic impact of Seth A. Wander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth A. Wander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth A. Wander more than expected).
Fields of papers citing papers by Seth A. Wander
This network shows the impact of papers produced by Seth A. Wander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth A. Wander. The network helps show where Seth A. Wander may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth A. Wander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 367 | |
| 2 | Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future Hit paper breakdown → | 2020 | 335 |
| 3 | ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer Hit paper breakdown → | 2021 | 211 |
| 4 | 2018 | 164 | |
| 5 | 2016 | 147 | |
| 6 | 2010 | 145 | |
| 7 | 2014 | 133 | |
| 8 | 2019 | 131 | |
| 9 | 2009 | 123 | |
| 10 | 2019 | 109 | |
| 11 | 2015 | 99 | |
| 12 | 2020 | 96 | |
| 13 | 2009 | 96 | |
| 14 | 2022 | 68 | |
| 15 | VERITAC-2: a Phase III study of vepdegestrant, a PROTAC ER degrader, versus fulvestrant in ER+/HER2- advanced breast cancer Hit paper breakdown → | 2024 | 59 |
| 16 | 2013 | 55 | |
| 17 | 2010 | 50 | |
| 18 | 2019 | 50 | |
| 19 | 2015 | 43 | |
| 20 | 2023 | 39 |
About Seth A. Wander
Seth A. Wander is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 113 papers that have together received 3.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (74 papers), Cancer Treatment and Pharmacology (24 papers), HER2/EGFR in Cancer Research (23 papers), Cancer Genomics and Diagnostics (19 papers), Cancer-related Molecular Pathways (16 papers), Breast Cancer Treatment Studies (15 papers), Acute Myeloid Leukemia Research (6 papers) and Estrogen and related hormone effects (6 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (689 citations), Pulmonary and Respiratory Medicine (1.1k citations), Genetics (304 citations) and Molecular Biology (1.3k citations). Seth A. Wander has collaborated with scholars based in United States, Italy and Israel. Frequent co-authors include Joyce M. Slingerland, Aditya Bardia, Laura M. Spring, Bryan T. Hennessy, Dekuang Zhao, Beverly Moy, Amir Fathi, Fabrice André, Nicholas C. Turner and Jamie O. Brett. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Blood and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.